At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.

Translate

French German Italian Portuguese Russian

Surgical Management of Post-Traumatic Occipital Migraines Study

Clinical Trial Title: 
Surgical management of post-traumatic migraines on maximal medicine therapy.
Clinical Trial Protocol ID: 
19021202-IRB01
Clinical Trial Investigator Name: 
Amir H. Dorafshar, MD
Clinical Trial Protocol Description: 

The purpose of this study is to determine if there is any superiority of one of the two current standard-of-care surgical treatments for often debilitating post-traumatic occipital migraines. These procedures involve freeing up or removing one or more of the occipital nerves deemed to be the source of these headaches. This is a single institution study at Rush University Medical Center, and there will be 25 patients enrolled in each study arm. The two standard-of-care procedures will be assigned to the study population randomly.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have a history of sharp or blunt head or neck trauma or a concussion as an inciting event for occipital headaches.
  • Have chronic headaches occurring in the occipital distribution (back of head) for over 1 year, as diagnosed by neurologist.
  • Are between 18 and 65 years of age.
  • Are male or female.

You will be excluded from the study if any of the following criteria apply to you:

  • Have a headache of any etiology other than specified in the inclusion criteria.
  • Have occipital referral of pain arising from the atlantoaxial or upper zygapophyseal joints or from tender trigger points in neck muscles or their insertions.
  • Are a pregnant or breastfeeding.
  • Have significant comorbidities including short life expectancy, malignancy, degenerative central nervous system diseases, infection, severe psychiatric disorders.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Plastic and Reconstructive Surgery
Contact Phone: 
(312) 563-3000
Contact Name: 
Amir H. Dorafshar, MD